Map kinase inhibitors

被引：0
|
作者：
不详
机构：
来源：
CHIMICA OGGI-CHEMISTRY TODAY | 1998年 / 16卷 / 1-2期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：50 / 50
页数：1
相关论文
共 50 条
  • [41] Erratum: Synergistic effects of ion transporter and MAP kinase pathway inhibitors in melanoma
    Ugur Eskiocak
    Vijayashree Ramesh
    Jennifer G. Gill
    Zhiyu Zhao
    Stacy W. Yuan
    Meng Wang
    Travis Vandergriff
    Mark Shackleton
    Elsa Quintana
    Arthur E. Frankel
    Timothy M. Johnson
    Ralph J. DeBerardinis
    Sean J. Morrison
    Nature Communications, 7
  • [42] The structural basis for the specificity of pyridinylimidazole inhibitors of p38 MAP kinase
    Wilson, KP
    McCaffrey, PG
    Hsiao, K
    Pazhanisamy, S
    Galullo, V
    Bemis, GW
    Fitzgibbon, MJ
    Garon, PR
    Murcko, MA
    Su, MSS
    CHEMISTRY & BIOLOGY, 1997, 4 (06): : 423 - 431
  • [43] Downregulation of chemokine production by MAP Kinase Inhibitors in human neutrophils and mononuclear cells
    Allen, RM
    Lukacs, NW
    Kunkel, SL
    FASEB JOURNAL, 1999, 13 (05): : A844 - A844
  • [44] 'Reverse' α-ketoamide-based p38 MAP kinase inhibitors
    Montalban, Antonio Garrido
    Boman, Erik
    Chang, Chau-Dung
    Ceide, Susana Conde
    Dahl, Russell
    Dalesandro, David
    Delaet, Nancy G. J.
    Erb, Eric
    Gibbs, Andrew
    Kahl, Jeff
    Kessler, Linda
    Lundstroem, Jan
    Miller, Stephen
    Nakanishi, Hiroshi
    Roberts, Ed
    Saiah, Eddine
    Sullivan, Robert
    Wang, Zhijun
    Larson, Christopher J.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (20) : 5456 - 5459
  • [45] A road map to evaluate the proteome-wide selectivity of covalent kinase inhibitors
    Lanning B.R.
    Whitby L.R.
    Dix M.M.
    Douhan J.
    Gilbert A.M.
    Hett E.C.
    Johnson T.O.
    Joslyn C.
    Kath J.C.
    Niessen S.
    Roberts L.R.
    Schnute M.E.
    Wang C.
    Hulce J.J.
    Wei B.
    Whiteley L.O.
    Hayward M.M.
    Cravatt B.F.
    Nature Chemical Biology, 2014, 10 (9) : 760 - 767
  • [46] A road map to evaluate the proteome-wide selectivity of covalent kinase inhibitors
    Lannine, Bryan R.
    Whitby, Landon R.
    Dix, Melissa M.
    Douhan, John
    Gilbert, Adam M.
    Hett, Erik C.
    Johnson, Theodore
    Joslynl, Chris
    Kath, John C.
    Niessen, Sherry
    Roberts, Lee R.
    Schnute, Mark E.
    Wang, Chu
    Hulce, Jonathan J.
    Wei, Baoxian
    Whiteley, Laurence O.
    Hayward, Matthew M.
    Cravatt, Benjamin F.
    NATURE CHEMICAL BIOLOGY, 2014, 10 (09) : 760 - 767
  • [47] Design and synthesis of potent pyridazine inhibitors of p38 MAP kinase
    Tamayo, N
    Liao, L
    Goldberg, M
    Powers, D
    Tudor, YY
    Yu, V
    Wong, LM
    Henkle, B
    Middleton, S
    Syed, R
    Harvey, T
    Jang, G
    Hungate, R
    Dominguez, C
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (09) : 2409 - 2413
  • [48] Discovery and design of benzimidazolone based inhibitors of p38 MAP kinase
    Hammach, Abdelhakim
    Barbosa, Antonio
    Gaenzler, Faith Corbo
    Fadra, Tazmeen
    Goldberg, Daniel
    Hao, Ming-Hong
    Kroe, Rachel R.
    Liu, Pingrong
    Qian, Kevin C.
    Ralph, Mark
    Sarko, Christopher
    Soleymanzadeh, Fariba
    Moss, Nell
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (24) : 6316 - 6320
  • [49] Natural and synthesized inhibitors of the MAP-kinase pathway study of their efficiency in vitro
    Saab, F.
    Routier, S.
    Beneteau, V.
    Merour, J. -Y.
    Schoentgen, F.
    EJC SUPPLEMENTS, 2008, 6 (09): : 147 - 147
  • [50] Optimization of the Development of Old and New EGFR and MAP Kinase Inhibitors for Colorectal Cancer
    Martinelli, Erika
    Napolitano, Stefania
    Ciardiello, Davide
    Ciardiello, Fortunato
    Troiani, Teresa
    CURRENT COLORECTAL CANCER REPORTS, 2014, 10 (03) : 279 - 287
12345